ArticleAnnals of the rheumatic diseases2023

Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial.

No numbers read from the abstract.

Not cited yet